Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) shares dropped 30.9% during mid-day trading on Thursday . The company traded as low as $0.60 and last traded at $0.60. Approximately 122 shares were traded during trading, a decline of 90% from the average daily volume of 1,267 shares. The stock had previously closed at $0.8680.
Mosaic ImmunoEngineering Stock Down 30.9%
The firm’s fifty day simple moving average is $0.68 and its 200-day simple moving average is $0.55. The company has a market cap of $4.35 million, a PE ratio of -6.00 and a beta of -1.04.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last issued its quarterly earnings data on Tuesday, August 19th. The company reported ($0.02) earnings per share for the quarter.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
See Also
- Five stocks we like better than Mosaic ImmunoEngineering
- What is Forex and How Does it Work?
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Ondas Holdings Signals a Rebound as Drone Demand Soars
- Why is the Ex-Dividend Date Significant to Investors?
- Disney’s 2026 Outlook Brightens Under Iger’s Magic Touch
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
